chrisvoncsefalvay/vaers-outcomes huggingface dataset:
HPI: This is a 17-year-old female brought in by mother presenting with syncope that was not witnessed earlier today.  Currently, patient endorses moderate and constant dizziness and shakiness.  Patient received her first dose of the Pfizer COVID-19 vaccination yesterday and currently endorses right upper arm pain.  Reexamination/Reevaluation  10/03/21 18:04:34 - I have reevaluated the patient at this time who states pain and symptoms have improved and requests to be discharged home at this time. Pt understands the findings of their studies completed today. Patient appears stable for discharge.  I discussed with her and her grandmother the need to start iron pills and all of the symptoms that, starting iron pills.  She was discharged with iron pills and constipation medications.  She is aware that her stool may change and also get darker.  She is aware that she needs to follow-up with a primary care doctor to get repeat blood tests.  We discussed all return precautions as well. Medical Decision Making  Based on H&P and testing, this patient?s microcytic anemia appears to be amenable for outpatient treatment.  Patient has not received a blood transfusion in the ED. The patient is at low risk for life threatening hemorrhage or secondary complications of anemia such as acute coronary syndrome etc.  The patient has been given strict return precautions and understands the need for further outpatient testing and treatment. Likely cause of mild anemia is menses.  After consideration of a broader differential, patient was diagnosed with weakness, dizziness, and postvaccination reaction and will be discharged home. Patient has currently been stabilized in the emergency department. Patient is non-toxic appearing and well hydrated. Patient?s symptoms not typical for other emergent causes that require further testing or treatment in the ED.  It was explained to patient that some disease processes can evolve over time. Although the patient does not have the signs and symptoms to indicate an emergent diagnosis at this time, the patient was made aware that this is a possibility in the future.  The patient was given strict return precautions and will follow up with primary MD in 1-2 days for further evaluation. Diagnosis/Assessment/Plan  1. Mild anemia  2. Shakiness  3. Dizziness  4. Post-vaccination reaction
Feeling asthmatic; not feeling well; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for a Female Patient that:   A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Formulation; Solution for Injection, Batch/Lot Number and Expiry date was not provided), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 Immunization. The patient's medical history and patient's concomitant medications were not reported. It was unknown that Reporter was a Healthcare Professional or prescribing HCP. The unaddressed medical questions were referred or forwarded to Medical Information. The patient experienced Feeling Asthmatic and Not feeling well on an unspecified date. Caller's mom got her 1st dose at their local hospital and she's supposed to get her 2nd dose but she's not feeling well and is feeling asthmatic. The events were assessed as Non serious. The outcome of events was unknown.    No follow up attempts are possible. Information about Lot/batch number cannot be obtained.
Shortly after receiving first dose, a small rectangular redness appeared on front of left shoulder.  Appeared it might have been fading slightly until second dose was received at which time redness returned and area became larger.  At time of this writing, red area appears to be losing rectangular shape and is now more like two separate spots on shoulder with a curved red line connecting  the two. Each separate area seems to have a bump which are connected to each other with a raised vessel of some sort  that runs through the curved red connecting line.
On 9/27/23 he received a Pfizer COVID vaccine. On 10/3/23 he presented to the hospital with paresthesia and progressive polyneuropathy. Imaging MRI, CT scan, LP completed during hospitalization. Current concern or GBS.
loosey; flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (loosey) and INFLUENZA (flu symptoms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (loosey) and INFLUENZA (flu symptoms). At the time of the report, VACCINATION COMPLICATION (loosey) and INFLUENZA (flu symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment were reported   Most recent FOLLOW-UP information incorporated above includes: On 18-Nov-2021: Follow-up received Updated No New Information.
20 min after immunization had a solid four hour episode of shrill crying and swelling, redness in 4cm area around injection site. Resolved spontaneously and no problems since.
Mild tenderness at injection site; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection; lot number: EJ1686, expiration date was unknown, NDC/UPC number unknown), via an unspecified route of administration on 13Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced mild tenderness at injection site on an unspecified date. The patient had the first vaccine on 13Jan2021 and was scheduled for the second dose on 01Feb2021 and was asking if that was the right scheduling or if that was the correct amount of time between the two injections. The outcome of the event was unknown.
Extreme lethargy, muscle cramps, headaches, mild fever--started approximately 12 hours after shot and lasted 12 hours.
Started with fever 101 and chills Nausea, slight headache, tired, slight aching ,tired for three days Fever from 99.2 - 101 for three days Took Tylenol
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient concerned a 29 year old female of unspecified ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A and expiry: 21-SEP-2021) 1 total, dose was not reported, administered to left arm on 04-MAY-2021 for prophylactic vaccination (dose number in series 1). No concomitant medications were reported. On 29-DEC-2021, the patient experienced confirmed clinical vaccination failure. The patient reported that she has covid (confirmed covid-19 infection) after receiving the Janssen covid 19 vaccine (dose number in series 1). On 29-DEC-2021, laboratory data included: COVID-19 PCR test (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the confirmed covid-19 infection and confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with Product quality compliant: 90000210291.; Sender's Comments: V0-20220107534-Covid-19 vaccine ad26.cov2.s- Confirmed Clinical Vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
Pt had intense pain and swelling with raised red circle starting that night of vaccination. Red circle got increased all the way to elbow from the injection site. Pt went to dr. She received rocephin there and then came to pharmacy and filled 2 rxs for omnicef 300mg bid x 10d, medrol 4mg dosepak.
Started to have itchy red rash in the right upper arm unrelieved by over the counter cortisone cream and antihistamine. Consulted PCP and prescribed Clobetasol  0.05% cream which gives good relief. But rash is noted to spread to upper chest area and right upper and lower arm. Felt like the vaccine has triggered something in my immune system to react this way in the form of itchy rashes.
12 to 24hr p/vax pt devel fever, myalgia & arthralgia;this report was recv 3wk post vax;the fever, myalgia & arthralgia persisted @ that time;pt was sl ill @ the time of vax;
Shot was given too high in arm. Severe pain that continues to this day. Pain every time I move my arm.
Pt vax;  exp fever 103F, local reaction & erythema multiforme.  Hosp x2 days.
Started to get hives along both arms, spread to my legs and back. It all started around 8:30 pm I was woken up by the itchiness on my arms.
couldn't remember when she got her 1st dose and didn't clarify if her memory loss was due to getting the Covid vaccine; This is a spontaneous report from a Pfizer-sponsored program . A non-contactable female consumer (patient) of an unspecified age reported that she received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that patient couldn't remember when she got first dose and it's not on any of her paperwork. On an unspecified date, the patient experienced couldn't remember when she got her 1st dose and didn't clarify if her memory loss was due to getting the Covid vaccine. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Our completely healthy daughter who never had a case of chicken pox was vaccinated for chicken pox in 1995.  Patient developed a horrible case of shingles at the young age of 13.  The loocation of the shingles was the nerve running the length of her right ear and down to her jaw.  Patient had yet another episode of shingles just recently at the age of 16.  Same location.  On both occassions she was in excruciating pain and missed a week of school.  In both instances the physicians initial diagnosis was incorrect and we had to return the follow day (one to the ER) to have the proper diagnosis and to begin the treatment of famvir and prednisone.  10/25/07 Per email from FDA: 294016 did not receive Zostavax vaccine (called physician)--patient received varicella in 1995, developed shingles x 2. 10/26/07 Reviewed hospital ER records of 9/29/2007 which reveal patient experienced pain of the right ear & cheek x 2 days, body aches, sore throat & fatigue x 2 wks.  Had been seen by pcp on 9/28 & given oral antibiotics & ear drops.  Exam revealed blinsters within right ear canal.  D/C to home w/antiviral, steroids & pain med FINAL DX: otalgia, herpes zoster.  10/26/07 Received internist medical records which reveal patient experienced good health on 8/8/07. Received Adacel that day. Next vs on 9/28/07 for right ear pain.  URI s/s week prior to ear pain.  Exam revealed no vesicles but w/erythema & edema, TM erythema.  Tx w/oral antibiotics. FINAL DX: otitis externa & otitis media. 11/30/07 Reviewed vax record from pcp & VAERS database updated w/same.
Patient in usual state of health today. Yesterday he received Typhoid vaccine without issue. Today he received his first dose of Anthrax and Yellow Fever vaccines and second dose of Meningococcal (MCV4P). After receiving his vaccines he attempted to stand and became light headed. He was noted to become pale and then lost consciousness for less than 5 seconds. He regained consciousness immediately without loss of bowel/bladder control, convulsions, or confusion. He denies nasal, ocular, cutaneous, laryngeal, pulmonary and GI symptoms. He denies adverse reaction to prior vaccines. He denies prior episodes of fainting/loss of consciousness.
hives with pruritus on right arm and lower extremities started on 22MAR2021.  Per Provider request to submit VAERS on behalf of patient.  Pt will be provide prescription, mometasone topical cream for the rash.
Paresthesias of right leg started on 12/26 and over the next month progressed to bilateral legs and bilateral arms paresthesias with associated nerve pain. Also developed bilateral hand stiffness. Diagnosed with Multiple Sclerosis Feb 2017.
2/19/2021 at 0300  - fever of 102.9 F, headache, body aches and chills 2/19/2021 at 0900 - fever of 102.8 F, headache, body aches and chills - took OTC Excedrin 2/19/2021 at 1100 - fever of 100.6 F, headache, body aches and chills 2/19/2021 at 1230 to 1430 - took a nap 2/19/2021 at 1430 - woke up with fever of 104.1 F - ice packs x 2 to neck, armpits and groin, took a cool bath - took Extra Strength Tylenol 2/19/2021 at 1520 - fever of 101.1 F 2/19/2021 at 1730 - temperature of 98.0 F 2/19/2021  at 2030 - temperature of 99.4 F 2/19/2021 at 2130 - temperature of 100.5 - went to bed
Dry cough ongoing.  Sneezing off and on and runny nose off and on
Not able to receive the second vaccine dose as scheduled; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Not able to receive the second vaccine dose as scheduled) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032120A) for an unknown indication.     The patient's past medical history included Carotid artery repair on 26-Feb-2021.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Not able to receive the second vaccine dose as scheduled). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Not able to receive the second vaccine dose as scheduled) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Computerised tomogram: abnormal (abnormal) abnormal scan of carotid artery.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Doctor performed surgery for carotid artery on 26-Feb-2021. Patient was scheduled to receive second vaccine dose on 27-Feb-2021.  This report refers to a case of product dose omission issue for mRNA-1273, with no associated AEs. Further information has been requested.; Sender's Comments: This report refers to a case of product dose omission issue for mRNA-1273, with no associated AEs. Further information has been requested.
Wen t home after first shot an immediately fell asleep for 7 hours.  I have never slept/napped in the day before.  In the days since then I have several bouts, every day, of wanting to sleep and spend hours drinking coffee and trying to stay awake.  What those shots have left me with is debilitating and I am afraid that I will be stuck with this for the rest of my life.  I read that  there is no cure for ME  If you can help, you have my contact information.  I would gladly be part of a study.
Injection given on 08/2/07 patient complained of localized redness, swelling and pain.
The next day after I received my vaccination around 0500 a.m., I had severe headache and left arm pain. At 0700 a.m., I had body aches, chills and a low grade fever 100.4. I took Tylenol and Advil interchangeably throughout the day. My fever was resolved that night but the rest of my symptoms (body aches, chills, headache, left arm pain) remained until the next day (Monday).
This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 25-year-old female patient who received Hepatitis B vaccine for prophylaxis. Co-suspect products included ENGERIX B ADULT for prophylaxis. Previously administered products included ENGERIX-B (1st dose received in August 2018). On an unknown date, the patient received Hepatitis B vaccine at an unknown dose and the 2nd dose of ENGERIX B ADULT. On an unknown date, not applicable after receiving Hepatitis B vaccine and unknown after receiving ENGERIX B ADULT, the patient experienced incomplete course of vaccination and therapeutic response decreased. On an unknown date, the outcome of the incomplete course of vaccination and therapeutic response decreased were unknown. It was unknown if the reporter considered the therapeutic response decreased to be related to Hepatitis B vaccine and ENGERIX B ADULT. Additional details were provided as follows: This case was reported by the patient mother. The batch number and expiry date was not reported. The reporter stated that the patient received the "full series as a child" but due to the patient's program of study a titre was completed. The patient was found to had levels under the target, which resulted in requiring additional immunization which led to decreased therapeutic response. The agent unable to confirm if the series administered in the patient's childhood was ENGERIX or another brand for the Hep B series. The patient had not yet received the series. This led to incomplete course of vaccination. Second or third dose to complete the. The reporter provided responsible prescriber name and phone number but did not have address available. Lab Comments: On unknown date, serology test was performed.
Pt developed fever, rash, pustules, worse in areas. Treated with Calamine lotion, increase in fluids, Motrin,  Tylenol and Pedialyte. Varicella.
Pricked cartilage in finger and drew blood with syringe before administering vaccine to patient; This spontaneous case was reported by a physician and describes the occurrence of UNDERDOSE (Pricked cartilage in finger and drew blood with syringe before administering vaccine to patient) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced UNDERDOSE (Pricked cartilage in finger and drew blood with syringe before administering vaccine to patient). On 14-Apr-2021, UNDERDOSE (Pricked cartilage in finger and drew blood with syringe before administering vaccine to patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On 07-May-2021, Dr. responded saying, patient received the complete dose and had no further issues.  No relevant concomitant medications reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: No specific follow-up information recorded.
Unknown exact start dates of adverse effect. Patient states his arm hurt and got red and the he developed an infection and went to his PCP who gave him a prescription for antibiotics.
pt recv vax 5NOV96 & 3-4min p/vax pt devel pallor & moist skin, & exp warmth & overall weakness for a period of 15min;pt also exp lightheadedness;pt also devel redness in the office;BP 102/74;
multiple allergies; Initial information regarding an unsolicited valid non-serious case was received from other health care professional (Lab manager) via Medical Information (Reference number- 00690017) and transmitted to Sanofi on 20-Jul-2021.  This case involved a female patient who experienced multiple allergies, while she received DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  Medical history, past medical treatment(s), vaccination(s) and family history were not provided.  At the time of the event, the patient had ongoing drug hypersensitivity (patient had reactions in the past to other vaccines).  Concomitant medications were not reported.  On an unknown date, the patient received an unknown dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot number: unknown and expiration date: unknown) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious event, "multiple allergies", (unknown latency) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE  It was reported that, "caller did not have any detail on the patient as far as specific allergens, nor did he have the details of the patient's reactions or to which vaccines she had reactions to".  No laboratory data was reported.  It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of the event was unknown.  There would be no information available regarding batch number in this case.
I received the Moderna COVID-19 booster on 7/12/2022. While I was vacationing abroad on 10/16/2022, I took a home antigen test for COVID-19, and the result was positive. I went to a walk-in clinic and saw a physician there. They did blood work. I have secondary chronic kidney disease. Because of this, I was dehydrated and my GFR was low, so they reduced the dose of the PAXLOVID they prescribed me. I isolated at the hotel for 5 days. My symptoms included coughing, runny nose, and irritated eyes. I thought that they were caused by an allergy at first, but I decided to test myself just to make sure my symptoms weren't caused by something else, and that was when I learned I that I was COVID-19-positive. While I was taking the PAXLOVID, though, the symptoms improved. I tested negative on 10/21/2022. I traveled back home on 10/21/2022. After I came home, I felt fine at first. Then I started coughing again around 11/1/2022. I took another test, which yielded a positive result. I called my doctor's office. I was told that since I had already taken PAXLOVID previously, I couldn't get another prescription. Instead, they recommended that I just isolate. I then isolated for 10 days. I took TYLENOL for my body aches and waited it out. After the second round of COVID-19, I had brain fog and a persistent cough that lingered after all the other symptoms were gone. I also experienced profound fatigue. At the time of this writing, I feel like I am getting some of my energy back. I also have some residual brain fog, and I have difficulty finding words. I also sometimes lose my train of thought and veer off on tangents.
Patient received ZOSTAVAX 2/18/16 on 2/20/16 comes in to pharmacy complaining of left sided pain similar to previous shingles pain in the past. Pain is located on belly radiates from mid-back to belly button. WO red marks discoloration. Injection site looked fine no redness. Recommended urgent care since weekend.
This is a spontaneous report from a contactable nurse via a Pfizer sales representative. A patient (unknown age and gender) may have received a dose of PREVENAR 13 on an unknown date. Relevant medical history and concomitant medications were not provided. On an unknown date a patient may have experienced apnea. The nurse queried the following: please advise as to the prevalence rate of apnea within the premature pediatric patient. The outcome of the event apnea was unknown. Follow-up (23May2012): Follow-up attempts completed. No further information expected.